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Abstract. Polymorphonuclear leukocytes (PMN) infil- 
tration into tissues is frequently accompanied by in- 
crease in vascular permeability. This suggests that PMN 
adhesion and transmigration could trigger modifica- 
tions in the architecture of endothelial cell-to-cell junc- 
tions. In the present paper, using indirect immunofluo- 
rescence, we found that PMN adhesion to tumor 
necrosis factor-activated endothelial cells (EC) in- 
duced the disappearance from endothelial cell-to-cell 
contacts of adherens junction (AJ) components: vascu- 
lar endothelial (VE)-cadherin, a-catenin, 13-catenin, 
and plakoglobin. Immunoprecipitation and Western 
blot analysis of the VE-cadherin/catenin complex 
showed that the amount of 13-catenin and plakoglobin 
was markedly reduced from the complex and from total 
cell extracts. In contrast, VE-cadherin and a-catenin 
were only partially affected. Disorganization of endo- 
thelial AJ by PMN was not accompanied by EC retrac- 
tion or injury and was specific for VE-cadherin/catenin 
complex, since platelet/endothelial cell adhesion mole- 
cule 1 (PECAM-1) distribution at cellular contacts was 
unchanged. PMN adhesion to EC seems to be a prereq- 
uisite for VE-cadherin/catenin complex disorganiza- 
tion. This phenomenon could be fully inhibited by 
blocking PMN adhesion with an anti-integrin 132 mAb, 
while it could be reproduced by any condition that in- 
duced increase of PMN adhesion, such as addition of 
PMA or an anti-i32-activating mAb. The effect on en- 
dothelial AJ was specific for PMN since adherent acti- 
vated lymphocytes  did not induce similar changes. High 
concentrations of protease inhibitors and oxygen me- 
tabolite scavengers were unable to prevent AJ disorga- 
nization mediated by PMN. PMN adhesion to EC was 
accompanied by increase in EC permeability in vitro. 
This effect was dependent on PMN adhesion, was not 
mediated by proteases and oxygen-reactive metabo- 
lites, and could be reproduced by EC treatment with 
EGTA. Finally, immunohistochemical analysis showed 
that VE-cadherin distribution was affected by PMN ad- 
hesion to the vessel wall in vivo too. 
This work suggests that PMN adhesion could trigger 
intracellular signals in EC that possibly regulate VE- 
cadherin/catenin complex disorganization. This effect 
could increase EC permeability and facilitate PMN 
transmigration during the acute inflammatory  reaction. 
NDOTnELIUM controls the passage of solutes and cir- 
culating cells from blood to tissues. This function 
requires highly effective intracellular and paracel- 
lular transport systems  (Franke et al.,  1988; Simionescu 
and Simionescu,  1991; Rippe and Haraldsson, 1994; De- 
jana et al.,  1995). The paracellular permeability is  con- 
trolled in large part by intercellular junctions. Endothelial 
cells (EC) 1 express at least four types of junctions: adher- 
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ence junctions (AJ),  tight junctions, gap junctions, and 
complexus  adherentes (Franke et al., 1988; Rubin, 1992; 
Dejana et al., 1995). Tight junctions and gap junctions are 
well developed in vessels where the control of permeabil- 
ity needs to be high, such as in large vessels, arteriolae, or 
the brain microcirculation  (Risau and Wolburg,  1990; Si- 
mionescu and Simionescu, 1991). Complexus adherentes is 
mostly developed in the lymphatic vasculature (Schmelz 
and Franke, 1993). In contrast, AJ are essentially ubiqui- 
tous.  In  postcapillary  venulae,  where  interchanges  be- 
tween blood and tissues need to be dynamic, paracellular 
permeability could be controlled essentially by AJ and by 
other adhesive molecules apparently not organized in spe- 
cific junctional organelles, such as platelet/endothelial cell 
adhesion molecule 1 (PECAM-1)  (Newman et al., 1990; 
DeLisser et al., 1994). AJ are formed by transmembrane 
Ca2+-dependent  adhesive proteins called cadherins, which 
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cytoskeletal molecules that in turn promote the anchorage 
to actin microfilaments (Takeichi, 1991; Geiger and Aya- 
lon, 1992; Tsukita et al., 1992; Kemler, 1993; Klymkowsky 
and Parr, 1995). 
An  endothelial-specific cadherin  has  been  identified: 
vascular endothelial (VE)-cadherin (or cadherin 5 or 7B4; 
Lampugnani et al., 1992; Breviario et al., 1995; Breier et al., 
1996).  VE-cadherin is complexed to cytoplasmic proteins 
named catenins, such as ot-catenin, 13-catenin, plakoglobin, 
and p120  cas (Lampugnani et al., 1995). EC also express sig- 
nificative amounts of N-cadherin. However, this molecule 
does not seem to play a major role in endothelial perme- 
ability since it is not organized at cell-to-cell contacts but 
remains diffused on the EC membrane (Salomon et al., 
1992). 
Polymorphonuclear leukocytes (PMN) are the first cells 
recruited from blood to sites of acute inflammatory reac- 
tion.  Circulating PMN  need first to adhere and  then to 
cross the endothelial lining of postcapillary venulae to en- 
ter the tissues. This process is  a  rapid event; once PMN 
stick to the luminal side of the endothelium, it takes only a 
few minutes to reach the subendothelial basal membrane 
(Marchesi and Florey, 1960). Adherent leukocytes can mi- 
grate  toward  endothelial  cell-to-cell junctions  and  then 
transmigrate  through  them.  This  process  is  frequently 
accompanied  by  increase  in  vascular  permeability  and 
oedema formation (Larsen et al., 1980). Oedema is an es- 
sential part of the host defense system since it controls the 
supply of complement and other reactive substances from 
blood to an infected tissue to regulate local killing of mi- 
croorganisms. Strong in vivo evidence indicates that PMN 
are required for oedema formation (Wedmore and Will- 
iams, 1981; Yi and Ulich, 1992), but the manner by which 
they could increase vascular permeability is still undeter- 
mined. 
While a  significant amount of information is available 
on  the  adhesive molecules regulating PMN  adhesion  to 
the vascular surface, we know little about the mechanisms 
that  regulate  the  passage  of PMN  through  endothelial 
junctions. An attractive hypothesis is that PMN adhesion 
could  coordinate  the  opening  of  interendothelial  junc- 
tions,  facilitating  in  this  way  their  transmigration.  This 
process would also increase EC paracellular permeability 
and facilitate oedema formation. To test this possibility, in 
the present study we analyzed endothelial AJ organization 
upon PMN adhesion. We used human umbilical vein en- 
dothelium, which, like postcapillary venulae, does not ex- 
press organized tight junctions (Dejana et al., 1995). 
We found that PMN adhesion to EC disrupted VE-cad- 
herin/catenin  complex. These molecules were  lost  from 
EC cell-to-cell contacts and a large amount of 13-catenin 
and plakoglobin disappeared from VE-cadherin immuno- 
precipitates and total cell extracts. These findings suggest 
that PMN adhesion to EC could transfer intracellular sig- 
nals that could induce AJ disorganization. 
Materials and Methods 
Materials 
Reagents  were  purchased  from  the  following  sources:  medium  199 
(M199),  RPMI  1640,  and  other  culture  reagents  from  Gibco-Europe 
(Paisley, UK); PBS (containing Ca  2÷ and Mg  2÷, unless otherwise speci- 
fied) from Mascia Brunelli (Milano, Italy); tissue culture and flasks from 
Falcon  (Becton  Dickinson  Labware,  Lincoln  Park,  NJ);  Lymphoprep 
from Nycomed Pharma AS (Oslo, Norway); Mowiol 4-88  from Calbio- 
chem-Novabiochem Corp.  (La Jolla, CA); Percoll and CNBr-activated 
Sepharose from Pharmacia (Uppsala, Sweden); paraformaldehyde, HRP, 
BSA, Tris, PMA, Ponceau S, human fibronectin, heparin, leupeptin, pep- 
statin,  polyoxyethylenesorbitan monolaurate  (Tween-20),  1,10-phenan- 
throline, PMSF, Triton X-100 (TX-100),  DAB, EDTA,  EGTA,  FITC- 
labeled phalloidin, human elastase, and cathepsin G from Sigma Chemical 
Co. (St. Louis, MO); OCT compound from Miles Laboratories (Elkhart, 
IN); superoxide dismutase (SOD) and catalase from Boehringer Mann- 
heim GmBH (Mannheim, Germany); human recombinant tumor necrosis 
factor (TNF) from Genzyme Corp. (Cambridge, MA); protein A-peroxi- 
dase  conjugate  and  sulfo-nitrohydroxysuccinimido-biotin from  Pierce 
Chemical  Co.  (Rockford, IL);  NP-40  from  BDH  Laboratory  Supplies 
(Latterworth, UK); eglin C from Ciba-Geigy (Basel, Switzerland); thime- 
rosal from Merck (Darmstadt, Germany); aprotinin (Trasylol) from Bayer 
(Leverkusen, Germany); BB-94 (Batimastat) from British Biotechnology 
(Oxford, UK); all electrophoretic reagents from Bio Rad Laboratories 
(Richmond, CA); Na251CrO4, and enhanced chemiluminescence (ECL) 
from Amersham Intl. (Little Chalfont, UK); HRP-conjugated streptavidin 
from Biospa Division (Milano, Italy); TRITC-conjugated swine anti-rab- 
bit  IgG  from Dakopatts  (Glostrup,  Denmark)  and TRITC-conjugated 
goat  anti-mouse, FITC-conjugated goat anti-mouse, and donkey anti- 
rabbit  IgG  from  Jackson  ImmunoResearch  Laboratories  Inc.,  (West 
Grove,  PA); Transwell polycarbonate membrane inserts (0.4-1xm pore 
size) from Costar Corp. (Cambridge, MA). 
Antibodies 
The following antibodies were used: mAb to human VE-cadherin TEA 
1.31 (Leach et al., 1993) and mAb 7B4 (Lampugnani et al., 1992); mAb to 
human plakoglobin PGS.1 (Cowin et al., 1986; Franke et al., 1987), kindly 
donated by Prof. W. Franke (German Cancer Research Center, Heidel- 
berg, Germany); rabbit purified Ig to human ~-catenin and  [3-catenin, 
kindly donated by Dr. D. Gulino (Laboratoire d'H6matologie, CEA, IN- 
SERM U217, Grenoble, France); mouse mAb to human PECAM-1 9Gll 
(British  Biotechnology);  blocking mAb  to  human  integrin  [32  TS1/18 
(American Type Culture Collection, Rockville, MD); activating mAb to 
human integrin [32 KIM 127, kindly donated by Dr.  Martyn  Robinson 
(Celltech Therapeutics, Berkshire, UK); mouse mAb to E-selectin BBIG- 
E4 (R & D Systems Europe, Abingdon, UK). 
Leukocytes 
Venous blood from healthy donors, who had not received any medication 
for at least 2 wk, was anticoagulated with trisodium citrate (3.8%, 1:9 vol/ 
vol). PMN were isolated by dextran sedimentation followed by Lympho- 
prep gradient and hypotonic lysis of erythrocytes, as previously described 
(Del Maschio et al., 1989). PMN were washed and resuspended at the fi- 
nal concentration of 3 ×  106 per ml in M199 containing 20% heat-inacti- 
vated FBS.  In some experiments, supernatants  of activated  PMN  and 
PMN-derived membrane fragments were exposed to EC monolayers (for 
10 min) to test their effect on the distribution of AJ components at cell-to- 
cell contacts. 
Supernatants of activated PMN were obtained after exposure of 3  × 
106 PMN per ml to 100 nM PMA (10 min, 37°C). Cells were rapidly centri- 
fuged, and supernatants were collected and kept at 4°C until use. Rough 
membrane fragments were recovered from the pellet of PMA-activated 
PMN (see above), resuspended in M199 (with 20% FBS), sonicated at 4°C 
by using 5-s bursts for 1 min in a Branson B15 Sonifier (Italscientifica, Mi- 
lano, Italy), and kept at 4°C until use. 
Mononuclear cells obtained from buffy coats of blood donations were 
centrifuged on Lymphoprep gradient, and then depleted of monocytes 
and natural killer cells by separation on 46% and subsequent density gra- 
dients of 50% Percoll (Allavena et al., 1991). 
Endothelial Cells 
EC were isolated from human umbilical vein, cultured in M199  supple- 
mented with 20% newborn calf serum, 50 ~g/ml endothelial cell growth 
supplement, and 100 p.g/ml heparin (M199 complete medium), and kept at 
37°C in a 5% CO2 humidified atmosphere., as previously described (Lam- 
pugnani et al., 1995). 
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PMN were added to confluent EC monolayers treated with 100 U/ml TNF 
for 20 h, at a final physiological leukocyte-EC ratio of 10:1. In a series of 
experiments, PMN were layered on resting EC, and adhesion was stimu- 
lated by adding the activating anti-132  mAb KIM 127 (1-10 p~g/ml) or 10 nM 
PMA. PMN were therefore incubated for 5 min at 37°C (except otherwise 
specified), and nonadherent cells were eliminated by two washings with 
PBS. Cells were then fixed and permeabilized for immunofluorescence 
microscopy or extracted for immunoprecipitation and Western blot analy- 
sis, as described below. 
In some experiments, before addition to TNF-treated EC, PMN were 
subjected to different treatments: 10 rain (22°C) with the metalloprotease 
inhibitor BB-94 (l-2 i~g/ml); 20 rain (22°C) with the anti-[32 mAb TS1/18 
(1:100 final dilution); 20 min (22°C) with a  combination of SOD (300 
U/ml) and catalase (300 U/ml); 30 min (22°C) with a mixture of serine pro- 
tease inhibitors (100 U/ml aprotinin, 500 p~M leupeptin, and 30 i~g/ml eglin 
C). All of these agents remained in the medium during the adhesion assay. 
In some experiments, PMN were added to EC treated with the anti-E- 
selectin mAb BBIG-E4 (5 fxg/ml) for 1 h (37°C). 
Preliminary experiments were performed with PMN resuspended in se- 
rum-free M199.  This was, however, an unfavorable situation since EC 
monolayers were severely injured by adherent PMN. To preserve the 
endothelial integrity, we subsequently used PMN resuspended in M199 
containing 20%  heat-inactivated FBS. Under this condition, endothelial 
integrity was maintained during PMN adhesion. Indeed, endothelial toxic- 
ity, quantified as release of 51Cr from labeled EC (Westlin and Gimbrone, 
1993),  was 3.9%  after  10 rain of PMN adhesion, 3.5%  after  10 rain of 
cathepsin G exposure, and 3.2% in basal conditions. 
Immunofluorescence Microscopy 
Immunofluorescence was analyzed as previously described in detail (Lam- 
pugnani et al., 1992). Cells were fixed with 3% paraformaldehyde and per- 
meabilized with 0.5% TX-100. In some experiments, to confirm with other 
fixation methods the results obtained, cells were fixed either with metha- 
nol (5 min at -20°C) or fixed and permeabilized at the same time with 3% 
paraformaldehyde containing 0.5% TX-100 (3 rain and an additional 15 
min with paraformaldehyde alone; Ayalon et al., 1994).  For PECAM-1 
and F-actin staining, incubation with the primary PECAM-1 mAb was fol- 
lowed by the TRITC-conjugated goat anti-mouse secondary antibody, in 
the presence of FITC-labeled phalloidin (2 mg/ml). For double staining, 
the primary step was either with mouse anti-VE-cadherin in combination 
with rabbit anti--a-catenin or mouse anti-plakoglobin in combination with 
rabbit  anti-[3-catenin. This was followed by TRITC-coupled goat anti- 
mouse in combination with FITC-coupled donkey anti-rabbit. Coverslips 
were then mounted in Mowiol 4-88 and examined with a microscope (Ax- 
iophot; Zeiss, Oberkkochen, Germany). Images were recorded on films 
with a  constant exposure of 40 s (T MAX P3200; Eastman Kodak Co., 
Rochester, NY). 
lmmunoprecipitation and Western Blot Analysis 
After PMN adhesion, confluent EC monolayers (~2.4 x  106 cells) were 
washed twice with PBS at 4°C, and then extracted with 1 ml per petri dish 
of TBS containing: 2 mM Ca  2+, 15 Ixg/ml leupeptin, 1 mM PMSF, 1 mg/ml 
pepstatin, 0.36 mM phenanthroline, 40 U/ml aprotinin, 30 ixg/ml eglln C, 
1% TX-100, 1% NP-40, for 25 rain on ice with occasional gentle agitation. 
Cell extracts were then centrifuged at 14,000 rpm for 5 min (4°C), and the 
supernatants was defined as a  TX-soluble fraction. The monolayer was 
gently washed three times with TBS containing protease inhibitors, and 
then extracted with 0.5 % SDS and 1% NP-40 in TBS containing protease 
inhibitors. The extract was collected, vigorously pipetted, and centrifuged 
at 14,000 rpm for 5 min (4°C). The supernatant was defined as a TX-insol- 
uble fraction (Lampugnani et al., 1995). 
In some experiments, PMN (2.1  X 106/ml, corresponding to ~70% of 
adherent cells) and TNF (100  U/ml)-treated  EC  (2.4  X  106) were  ex- 
tracted  separately and subsequently mixed together for 20 min at 4°C. 
Samples were subsequently immunoprecipitated with 7B4-CNBr Sepharose 
and analyzed for the presence of VE-cadherin and catenins as described 
above. 
For immunoprecipitation, cell extracts (TX-soluble fraction) were mixed 
with the anti-VE-cadherin 7B4 mAb covalently coupled to CNBr-acti- 
vated Sepharose 4B (7B4-CNBr Sepharose). 7B4 was coupled at 1.8 mg 
per ml of CNBr-activated Sepharose 4B, according to the manufacturer's 
instructions. 7B4-CNBr Sepharose was then blocked and processed, ac- 
cording to the manufacturer's instructions, and stored at 4°C in the pres- 
ence of 0.02% NAN3. Before use, 7B4-CNBr Sepharose was washed three 
times with TBS containing 1 mM PMSF, 2 mM Ca  2+, 40 U/ml aprotinin, and 
1% TX-100. Cell extracts (1,000 I~1, corresponding to 2.4 x  l& endothelial 
cells) were mixed with 7B4-CNBr Sepharose (10 txl) for 2 h at 4°C under 
over-end rotation. Immunoprecipitates were washed six times with 500 pJ 
of 10 mM Tris, 0.5 M NaCI, 1 mM PMSF, 2 mM Ca  2+, 40 U/ml aprotinin, 
0.05%  NP-40, pH 7.4.  Immunoprecipitates were  treated  with Laemmli 
sample buffer (Laemmli, 1970), containing 2-mercaptoethanol (5% final 
concentration), to elute bound proteins that were then resolved by SDS- 
PAGE. After SDS-PAGE, gels were incubated twice (15 min each) with 
transfer buffer (50 mM Tris-HCl, 95 mM glycine) and transferred electro- 
phoretically to nitrocellulose filters (Towbin et al., 1979). After Ponceau S 
staining, filters were blocked with 10% lowfat milk in PBS, 0.05% Tween- 
20, and 0.01% thimerosal (washing buffer) and incubated with appropri- 
ate antibodies for 1 h at 22°C. 
For immunoblotting, hybridoma culture supernatants containing mAbs 
directed to VE-cadherin and plakoglobin were used diluted 1:2 in washing 
buffer containing 1% BSA instead of milk, while rabbit lgG to et-eatenin 
and 13-catenin  were used at 30 and 200 p,g/ml, respectively, in the same 
buffer. Filters were washed, incubated (1 h at 22°C) with 2.5 p,g/ml rabbit 
anti-mouse lgG when required, and then incubated (1 h  at 22°C) with 
protein  A-peroxidase conjugate (1:10,000),  followed  by detection  with 
ECL (Lampugnani et al., 1995). 
In some experiments, after PMN adhesion, confluent EC monolayers 
were washed twice in serum-free M199 and twice in PBS; then the cells 
were  treated  with 0.5 mg/ml of sulfo-nitrohydroxysuccinimido-biotin in 
PBS for 20 min at 4°C. After the incubation, cells were washed twice with 
PBS and twice with serum-free medium, and then extracted (TX-soluble 
fraction), as described above. Labeled cell lysates were immunoprecipi- 
tated as previously described, and immunocomplexes were subjected to 
SDS-PAGE  and  transferred  to  nitrocellulose.  The  nitrocellulose  after 
blocking was incubated with streptavidin-peroxidase conjugate (1:5,000, 
final concentration) in PBS containing 1%  BSA, 0.05%  Tween-20, and 
0.01% thimerosal for 1 h at 22°C, followed by detection with ECL. 
Immunohistochemistry 
Fragments of human tonsils were obtained at surgery. Tissue fragments 
were embedded in OCT compound, snap frozen in liquid nitrogen, and 
stored at -80°C until sectioning. Cryostat sections were fixed in acetone 
for 10 min at 22°C and immunostained with the anti-VE-cadherin mAb 
TEA 1.31  using avidin-biotin-peroxidase complex technique. The speci- 
mens were then processed and analyzed as previously described (Lampu- 
gnani et al., 1992). 
Endothelial Permeability  Assay 
EC were cultured on fibronectin-coated (10 p.g/ml) polycarbonate mem- 
branes of Transwell inserts (0,4-1xm pore size) for 5 d (with daily refeed- 
ing), and then treated with 100 U/ml TNF for 20 h, Transwell inserts were 
subsequently filled with 100 ~1 of M199 (+ 20% FBS) containing 6 Ixg/ml 
of HRP or 100 ixl of PMN (3 X 106/ml, resuspended in the same medium) 
either untreated or treated with TS1/18 mAb (1:100  final dilution, for 20 
rain) or SOD and catalase (300 U/ml, for 20 rain), or a cocktail of protease 
inhibitors (100 U/ml aprotinin, 500 p,M leupeptin, 30 Ixg/ml eglin C, for 30 
rain). In separate wells, EC were exposed to 2 mM EGTA. As previously 
described, in this assay, the passage of HRP reaches an equilibrium after 
60 rain of incubation (Navarro et al., 1995).  After this interval, the me- 
dium in the lower compartment was collected and kept on ice until the as- 
say of HRP enzymatic activity, as previously described (Ortiz de Montell- 
ano et al., 1988; Lampugnani et al., 1992; Navarro et al., 1995). 
Results 
Effect of  PMN Adhesion on Endothelial 
AJ Organization 
In confluent EC, AJ components are localized at cell-to-cell 
contacts. Indirect immunofluorescence analysis shows that 
antibodies directed to VE-cadherin and catenins (et-cate- 
nin,  13-catenin,  and plakoglobin) give a  fine, continuous 
staining of intercellular margins (Figs. 1, a and b, and 2, a 
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hesion  on  VE-cadherin  and 
13-catenin localization in EC. 
Resting or TNF-activated EC 
(100 U/ml, 20 h), in the pres- 
ence or absence of PMN (3 × 
106/ml), were double  stained 
for VE-cadherin  and  13-cate- 
nin.  PMN  were  incubated 
with  EC  for 5  rain  at  37°C. 
VE-cadherin  and  13-catenin 
were concentrated at cell-to- 
cell contacts in resting EC in 
the presence (c and d) or ab- 
sence of PMN (u and b), or in 
TNF-activated EC in the ab- 
sence  of PMN  (e  and f).  In 
contrast,  in TNF-treated EC 
in the presence of PMN, VE- 
cadherin and ~-catenin stain- 
ing was markedly reduced (g 
and h). (Arrowheads) Adher- 
ent PMN. PMN adhesion was 
only  observed  on  TNF- 
treated EC. Bar, 10 ixm. 
and  b). EC  treatment  with  TNF  (100  U/ml for 20 h)  did 
not change VE-cadherin  and catenin distribution  (Figs.  1, 
e  and f,  and 2, e  and JO. When  washed PMN  (3  x  106/ml) 
were  added to resting EC monolayers, they adhered  very 
poorly, and no significant change in the organization of en- 
dothelial  AJ components  was observed  (Figs.  1, c  and  d, 
and 2, c  and d). In contrast,  when PMN adhered  to TNF- 
treated EC monolayers (Figs.  1, g  and h,  and 2, g  and h), 
VE-cadherin and catenin (et-catenin, 13-catenin, and plako- 
globin) staining  at interendothelial  junctions  was strongly 
reduced. This effect was rapid, partially detectable at 1 min 
after PMN adhesion and maximal within 5 min. No differ- 
ence was observed by treating EC with TNF for 4, 6, or 20 h 
(not  shown).  Therefore,  in  all  the  experiments  reported 
below, EC  were  treated  with  TNF,  100 U/ml, for a  stan- 
dard time of 20 h. 
Maximal  effect was observed when  PMN  were  layered 
on TNF-treated EC at the concentration of 3 x  106/ml (ex- 
perimental  PMN/EC  ratio  of 10:1).  Under  this  condition, 
about six to seven PMN were found  adherent  to one EC. 
When PMN were layered at a concentration of 1.5  x  106/ml 
(about  three  to  four  adherent  PMN/EC),  the  effect was 
still observed,  although  with  a  minor intensity.  In all the 
experiments  reported  below,  a  concentration  of 3  ×  106 
PMN per ml was used. 
PECAM-1  and F-actin staining  of EC shows that PMN 
adhesion  did  not  induce  EC  retraction  (Fig.  3).  In  addi- 
tion,  it  also indicates  that the  effect was specific for VE- 
cadherin  and  catenins  since  PECAM-1  distribution  re- 
mained unaffected. 
Fig. 3 reports the results obtained with a  5-min incuba- 
tion  of PMN  with  EC,  but  comparable  results  were  ob- 
tained  by prolonging  the  incubation  for up to 60 rain.  In 
parallel, no significant EC toxicity, as measured by 51Cr re- 
lease,  was  observed  up  to  60  min  of  PMN  adhesion  to 
TNF-treated EC (not shown). 
To explore the  quantitative  significance  of the  changes 
in  junctional  protein  distribution  upon  PMN  adhesion, 
cells were extracted and VE-cadherin immunoprecipitates 
blotted  with  antibodies  to  VE-cadherin  and  catenins,  as 
previously described (Lampugnani et al., 1995). 
In VE-cadherin immunoprecipitates, antibodies to ct-cate- 
nin,  [3-catenin,  and  plakoglobin  recognized  bands  of 100, 
93,  and 83-80 kD, respectively (Fig. 4). As previoulsy de- 
scribed,  plakoglobin  appears  in  all  the  experiments  as  a 
triplet (Lampugnani et al., 1995). 
Addition of PMN to TNF-treated EC induced  a marked 
reduction  of [3-catenin and plakoglobin associated to VE- 
cadherin.  VE-cadherin  and  tx-catenin  appeared  less  af- 
fected  (Fig.  4).  A  similar reduction  of the  components  of 
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hesion on e~-catenin and pla- 
koglobin  localization  in  EC. 
Resting or TNF-activated EC 
(100 U/ml, 20 h), in the pres- 
ence or absence of PMN (3 x 
106/ml), were double stained 
for c~-catenin  and  plakoglo- 
bin.  PMN  were  incubated 
with  EC for 5  min at  37°C. 
a-Catenin  and  plakoglobin 
were concentrated at cell-to- 
cell contacts in resting EC in 
the presence (c and d) or ab- 
sence of PMN (a and b), or in 
TNF-activated EC in the ab- 
sence  of PMN  (e and f).  In 
contrast, in TNF-treated EC 
in  the  presence  of  PMN, 
a-catenin  and  plakoglobin 
staining  was  markedly  re- 
duced (g and h ). (Arrowheads) 
Adherent PMN. PMN adhe- 
sion  was  only  observed  on 
TNF-treated EC. Bar, 10 I~m. 
VE-cadherin/catenin  complex  was  observed  in  the  total 
cell extracts (Fig. 4). 
When Western blot was performed on the TX-insoluble 
fraction of the total cell extracts (see Materials and Meth- 
ods), a  similar decrease in [3-catenin and plakoglobin was 
observed (Fig. 5). 
Western blot analysis of extracts of PMN alone showed 
that  these  cells did not express measurable  levels of VE- 
cadherin, c~-catenin,  13-catenin,  and plakoglobin (not shown). 
Therefore, the AJ components detected  in the assays are 
exclusively of endothelial origin. 
Treatment  of EC with TNF in the absence of PMN did 
not  significantly  change  the  amount  of AJ  components 
(Fig. 4). In a few experiments, we observed some decrease 
of VE-cadherin and catenins even when EC were exposed 
to PMN in the absence of TNF pretreatment  (see, for in- 
stance, Fig. 4 A). In these experiments, however, some ad- 
hesion  of PMN  to  resting  EC  was  observed.  We  inter- 
preted these results as a consequence of a slight activation 
of PMN during the isolation and washing procedure. 
Finally, to evaluate the degree of VE-cadherin internal- 
ization, TNF-treated EC were incubated with PMN for 5 
min. Cells were then exposed to sulfo-nitrohydroxysuccin- 
imido-biotin and immunoprecipitated with a VE-cadherin 
mAb. By avidin-HRP blotting, we detected one band with 
the  expected  apparent  molecular mass of 130 kD.  A  de- 
crease of ,'-~30% was observed in the amount of VE-cad- 
herin  immunoprecipitated  with  adherent  PMN,  with  re- 
spect to the amount immunoprecipitated in the absence of 
PMN  (not  shown).  These  data  indicate  that,  upon PMN 
adhesion,  VE-cadherin's  disappearance  from  cell-to-cell 
contacts is partially due to its internalization.  However, a 
large part of the loss in immunofluorescence staining at in- 
tercellular  junctions  is  likely related  to  the  fact that  the 
molecule diffuses on the cell surface. 
PMN Adhesion to EC Is a Prerequisite for 
AJ Disorganization 
To investigate whether the physical contact between intact 
PMN and EC is required for AJ disorganization, PMN and 
TNF-treated EC were lysed and extracted separately. The 
two cell extracts were then mixed together (see Materials 
and Methods),  and  the  components  of the VE-cadherin/ 
catenin  complex were  analyzed  by  immunoprecipitation 
and Western blot. In these conditions, the amount of VE- 
cadherin and catenins remained unchanged (Fig. 4 B). 
In other experiments,  we studied whether the block of 
PMN  adhesion  would  inhibit  AJ  disassembly  in  TNF- 
treated EC. As above, EC were treated with TNF for 20 h. 
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F-actin  organization  in  EC 
in  the presence of adherent 
PMN.  Cells  were  double 
stained  for  PECAM-1  and 
F-actin  in  resting  (a-d)  or 
TNF-activated EC (100 U/ml, 
20 h) (e and f), either in the 
presence (c-f) or absence (a 
and b) of PMN (3 x  106/ml). 
PMN  were  incubated  with 
EC for 5 min at 37°C. A PE- 
CAM-1  mAb  gave  an  in- 
tense,  continuous  staining  of 
EC  at  cell-to-cell  contacts. 
Both PECAM-1  and F-actin 
distribution  remained identi- 
cal in all the situations  con- 
sidered.  EC  retraction  or 
opening of gaps at cell-to-cell 
contacts  could  never be ob- 
served.  (Arrowheads) Ad- 
herent PMN. Bar, 10 Ixm. 
In these  conditions,  EC  expressed intercellular  adhesion 
molecule (ICAM) 2, increased ICAM-1 and vascular cel- 
lular adhesion molecule (VCAM) 1 levels, but not signifi- 
cant E-selectin (Bevilacqua, 1993).  Since PMN commonly 
do not bind VCAM-1, [32 integrin receptors should play a 
major  role  in  promoting  their  adhesion  to  EC.  Indeed, 
when PMN were treated with the  anti-[32 blocking mAb 
TS1/18 and then added to TNF-treated EC, their adhesion 
was essentially abolished.  Basal and TNF-dependent ad- 
hesion was 20  ___ 8 and 173  ___  12  ×103 PMN per well, re- 
spectively, in  the  presence  of an  irrelevant  control  anti- 
body, and became 7  ___ 2 and 32 ___ 11  xl03 PMN per well, 
respectively, in the presence of TS1/18 mAb. As expected, 
PMN adhesion was unaffected by EC treatment with the 
E-selectin-blocking mAb BBIG-E4 (not shown). 
As assessed by immunofluorescence, in the presence of 
PMN  treated  with  TS  1/18,  the  distribution  of VE-cad- 
herin,  [3-catenin (Fig. 6), a-catenin, and plakoglobin (not 
shown)  in  TNF-treated  EC  remained  unchanged.  Simi- 
larly, by immunoprecipitation/Western blot analysis of AJ 
components in the presence of TS 1/18 mAb, no significant 
change  in  VE-cadherin/catenin  complex  was  observed 
(Fig. 7, lane 3). 
We then asked whether TNF activation of EC was nec- 
essary for the  observed changes in  AJ organization.  We 
therefore analyzed the effect of PMN adhesion on resting 
EC.  Adhesion  was first induced  by exposing PMN to 10 
nM PMA for 5 min. Plakoglobin (Fig. 8), VE-cadherin, 
a-catenin,  and  [3-catenin  (not  shown)  distribution  at EC 
junctions  was not  modified by PMA  alone  (Fig.  8,  com- 
pare a  with  b).  However, when PMN were  activated by 
PMA,  their  adhesion  was increased  by fivefold, and  AJ 
components  disappeared  at  endothelial  cell-to-cell  con- 
tacts (Fig. 8, compare c with a and b). 
PMN  adhesion  was  then  induced  by the  [32-activating 
mAb KIM 127 (Ortlepp et al., 1995). When PMN were ex- 
posed to KIM 127 (10 p~g/ml) for 5 min, their adhesion to 
resting EC was increased by 10-fold (not shown). In these 
conditions,  staining of a-catenin,  [3-catenin, VE-cadherin 
(not shown), and plakoglobin was essentially undetectable 
(Fig. 8 f). When KIM 127 was used at a lower concentra- 
tion  (1  ixg/ml), PMN  adhesion was increased  on the  EC 
monolayer but  in  a  nonhomogeneous way. Interestingly, 
AJ  components  disappeared  from  cell-to-cell  contacts 
only where PMN were firmly adherent to EC, but they re- 
mained intact in the areas devoid of adherent PMN (Fig. 8, 
compare d with e). 
To test the specificity of the effect of PMN on endothe- 
lial A J, we tested T-lymphocyte adhesion to EC.  T-lym- 
phocytes (3 ×  106/ml) were added to EC treated with TNF 
(100 U/ml, 20 h), and then stimulated with 10 nM PMA for 
10 min. As shown in Fig.  9,  endothelial  AJ organization 
was  not  modified  by  adherent  T-lymphocytes. In  these 
conditions,  the  number  of  adherent  T-lymphocytes was 
seven to eight per one EC. This value was comparable to 
that of adhering PMN  (six to seven per one EC)  in  our 
standard conditions (see also above). 
PMN-derived Proteases and Toxic Oxygen Metabolites 
Did Not Modify Endothelial AJ 
To further  investigate the  role  of PMN  adhesion  versus 
that of PMN-released soluble products, we asked whether 
PMN-derived proteases or toxic oxygen metabolites could 
be responsible for the observed changes in VE-cadherin/ 
catenin complex. 
We first evaluated the effect of the combination of the 
whole products released by activated PMN. Supernatants 
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of whole EC lysates. Confluent EC monolayers were treated ei- 
ther with TNF (100 D/ml) or medium alone for 20 h. PMN (3 × 
106/ml) or medium alone was added for 5 min at 37°C, and cells 
were washed and extracted as described in Materials and Meth- 
ods section. Aliquots of cell extracts were run in 7% SDS-PAGE 
under reducing conditions, transferred to nitrocellulose, and then 
analyzed for the presence of VE-cadherin, et-catenin, 13-catenin, 
and plakoglobin by immunoblotting. 
Figure 4.  (A) Effect of PMN adhesion on VE-cadherin, o~-cate- 
nin,  13-catenin,  and  plakoglobin  coimmunoprecipitation.  (VE- 
cadherin  immunoprecipitate)  Confluent  EC  monolayers  were 
treated either with TNF (100  U/ml) or medium alone for 20 h. 
PMN (3 ×  106/ml) or medium alone was added for 5 min at 37°C. 
EC were then washed and extracted as described (see Materials 
and Methods). Cell extracts were immunoprecipitated with 7B4- 
CNBr Sepharose, run in a 7% SDS-PAGE under reducing con- 
ditions,  and  then  analyzed  for  the  presence  of VE-cadherin, 
ct-catenin,  [3-catenin,  and  plakoglobin by  immunoblotting.  To 
save antibody and to directly compare the level of VE-cadherin 
and catenins in the same sample, after blotting the nitrocellulose 
was cut perpendicularly to the direction of protein run, separat- 
ing the areas of VE-cadherin and each catenin band as described 
(Lampugnani et al., 1995).  This was done with the reference of 
molecular weight standards. The sheets were then reacted with 
the appropriate antibody. (Total)  Aliquots of cell extracts were 
run in 7% SDS-PAGE under reducing conditions, transferred to 
nitrocellulose, and  then  analyzed for the  presence of VE-cad- 
herin, ct-catenin, 13-catenin, and plakoglobin by immunoblotting. 
(B) Effect of the physical contact between intact PMN and EC on 
VE-cadherin,  13-catenin,  and  plakoglobin  coimmunoprecipita- 
ton. (VE-cadherin immunoprecipitate) Confluent EC monolayers 
were treated either with TNF (100  U/ml) or medium alone for 
20h. PMN (3 x  106/ml) or medium alone was added for 5 rain at 
37°C,  and cells were washed and extracted. EC and PMN were 
also extracted separately, and then mixed together as described 
in  Materials and  Methods.  Cell extracts were  immunoprecipi- 
tated with 7B4-CNBr Sepharose, run in a 7% SDS-PAGE under 
reducing conditions, and then analyzed for the presence of VE- 
cadherin, 13-catenin, and plakoglobin by immunoblotting as de- 
scribed for A. (Total) As for A. The migration of molecular mass 
markers is shown on the right. 
of PMA-activated PMN, added to EC for 10 min, did not 
modify  AJ  components  as  assessed  by  immunofluores- 
cence (not shown) and by immunoprecipitation and West- 
ern blot analysis (Fig. 7). 
To  substantiate  the  effect  of unstable  components  re- 
leased  during  PMN  activation,  PMN  were  layered  on 
Transwell filters (0.4-txm pore size) to hinder their direct 
contact  with  EC  monolayers cultured  in  the  lower com- 
partment. PMN were then exposed to PMA, and VE-cad- 
herin/catenin distribution was examined by indirect immu- 
nofluorescence. After 10 min of PMN  exposure to PMA 
(0.1  to  1,000  nM),  AJ  organization was  unchanged  (not 
shown). 
Release  of  proteolytic enzymes,  such  as  elastase  and 
cathepsin  G,  by activated PMN  may  induce  endothelial 
damage (Peterson, 1989; Lampugnani et al., 1992). For this 
reason, in  this work,  adhesion assays were  performed  in 
the presence of 20% heat-inactivated FBS, which contains 
a  large amount  of natural protease inhibitors (Travis and 
Salvesen,  1983).  For  an  additional  block  of  PMN  pro- 
teases, the effect of PMN  adhesion to TNF-activated EC 
was tested in the presence of a  cocktail of inhibitors (100 
U/ml aprotinin, 500 I~M leupeptin, and 30 Ixg/ml eglin C). 
The antiprotease cocktail added during the adhesion assay 
did not prevent the disappearence of AJ components, as 
assessed by immunofluorescence (Fig. 10, e and/') and im- 
munoprecipitation-Western blot analysis (Fig. 7, lane 4). 
We next investigated the direct effect of a  combination 
of elastase and cathepsin G  directly added to EC cultured 
medium. Endothelial VE-cadherin/catenin complex orga- 
nization was not altered upon EC exposure to a  high con- 
centration (1  ixg/ml) of both elastase and cathepsin G  for 
10 min  (Fig. 10, i  and j). During PMN  activation, part of 
elastase and cathepsin G  activity might remain associated 
to  the  PMN  membrane  (Owen  et  al.,  1995).  However, 
when  membrane  fragments derived from PMA-activated 
PMN (see Materials and Methods) were incubated on EC 
monolayers for 10 min, no detectable modification of VE- 
cadherin  and  catenin  immunofluoresccnce  staining  was 
observed (not shown). 
Leukocyte metalloproteases released during inflamma- 
tory diseases play a  role in oedema formation and leuko- 
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with  the  anti-132  integrin 
blocking  mAb  TS1/18  pre- 
vents  the  disappearance  of 
VE-cadherin  and  13-catenin 
staining  at  cell-to-cell  con- 
tacts. TNF-activated EC (100 
U/ml, 20 h) in the presence or 
absence of PMN (3 x  106/ml) 
were double stained for VE- 
cadherin  and  [3-catenin. 
PMN  either  untreated  or 
treated with TS1/18 (1:100 fi- 
nal dilution; 20 min at 22°C) 
were incubated with EC for 5 
min  at  37°C.  VE-cadherin 
and  13-catenin  staining  was 
concentrated  in  the  regions 
of cell-to-cell  contact in  the 
absence  of PMN  (a  and  b). 
As previously shown, in the 
presence of PMN, staining of 
VE-cadherin  and  [3-catenin 
disappeared from cell-to-cell 
contacts (c and d).  Addition 
of TS1/18  blocked PMN ad- 
hesion and VE-cadherin and 13-catenin disappearance (compare e and f with a and b).  Comparable results were obtained when EC 
were double stained with antibodies to a-catenin and plakoglobin. (Arrowheads) Adherent PMN. Bar, 10 ixm. 
Figure 7.  Effect of the anti-132 integrin blocking mAb, protease 
inhibitors,  and supernatant  from PMA-activated PMN on VE- 
cadherin,  ct-catenin,  13-catenin, and  plakoglobin coimmunopre- 
cipitation.  Confluent  EC monolayers were  treated  either  with 
TNF (100 U/ml) or medium alone for 20 h. PMN (3  x  106/ml) 
were previously treated with anti-132 mAb (1:100 final concentra- 
tion for 20 min at 22°C) or with a cocktail of protease inhibitors 
(100 U/ml aprotinin, 500 ~,M leupeptin, and 30 Ixg/ml eglin C) for 
20 min at 22°C. The agents were then kept in the medium during 
PMN adhesion assay that was for 5 min at 37°C, as previoulsy de- 
scribed.  PMN supernatants were produced by treating PMN with 
100 nM PMA (10 min at 37°C). PMN were then rapidly centri- 
fuged  at  14,000 rpm,  and  the  supernatant  was incubated  with 
TNF-treated EC for 10 min. At the end of the incubation period, 
cells were washed and extracted. Cell extracts were then analyzed 
by immunoprecipitation with 7B4-CNBr Sepharose and immuno- 
blotting of VE-cadherin, c~-catenin, 13-catenin, and plakoglobin as 
described in the legend to Fig.  4. Molecular mass markers  are 
shown on the right. 
cyte infiltration  (Goetzl et  al.,  1996).  We have  therefore 
performed experiments with PMN treated with the metal- 
loprotease  inhibitor  BB-94  (Botos  et  al.,  1996).  As  as- 
sessed by immunofluorescence analysis, BB-94 (1-2 p,g/ml) 
did not prevent  the disruption  of endothelial  AJ compo- 
nents after PMN adhesion to TNF-treated EC (not shown). 
Superoxide  anions  and  hydrogen  peroxide  that  origi- 
nated during PMN respiratory burst could affect EC mono- 
layer integrity  by inducing cell  retraction  and  increasing 
endothelial  permeability  (Sacks  et  al.,  1978;  Carlos  and 
Harlan,  1994;  Bradley  et  al.,  1995).  We  therefore  tested 
whether the generation of these toxic oxygen metabolites 
could be responsible for the changes in endothelial AJ or- 
ganization observed. Immunofluorescence analysis showed 
that  VE-cadherin/catenin  complex  of  TNF-treated  EC 
junctions was similarly disorganized by adherent PMN, ei- 
ther untreated or treated with 300 U/ml of SOD and cata- 
lase (Fig. 10, g and h). 
In all of the experiments above, the concentration of in- 
hibitors selected was highly in excess with respect to that 
required  to block the total amount of proteases  and oxy- 
gen metabolites potentially released  by an equal number 
of activated  PMN  (Sacks  et  al.,  1978; Weiss  et  al.,  1981; 
Owen et al., 1995). 
Taken  together,  these  results  strongly suggest that  the 
changes in endothelial  AJ organization induced by PMN 
are not mediated by the extracellular release of soluble re- 
active components. 
AJ Disorganization Induced by PMN 
Adhesion Is Accompanied by an Increase in 
Endothelial Permeability 
We then studied whether the observed changes in VE-cad- 
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KIM 127-induced  PMN  ad- 
hesion on AJ organization in 
EC. Resting EC were stained 
for plakoglobin in conditions 
in which PMN adhesion was 
induced by PMA (10 nM) or 
KIM 127 (1 pg/ml, 10 ixg/ml) 
for 5 min at 37°C. In the ab- 
sence  of PMN,  plakoglobin 
staining was concentrated  in 
the  regions  of  cell-to-cell 
contact  both  in  resting  (a) 
and PMA-activated  EC (b). 
In  the  presence  of  PMN, 
when adhesion was induced 
by PMA (c) or KIM 127 (e 
and )'), plakoglobin  staining 
disappeared  at  endothelial 
AJ. Adherent PMN were not 
homogeneously  distributed 
in the endothelial monolayer 
after their exposure to 1 ixg/ 
ml KIM 127. (d and e) Two 
different areas from the same 
coverslip, plakoglobin  stain- 
ing  disappeared  only in  the 
area  with  adherent  PMN 
(compare d with e). Compa- 
rable  results were  obtained 
when EC were  stained  with 
VE-cadherin,  ct-catenin,  or 
13-catenin  antibodies.  (Ar- 
rowheads)  Adherent  PMN. 
Bar, 10 ixm. 
herin  and catenins  at EC contacts could have biological 
consequences. It was previously observed that the disorga- 
nization  of VE-cadherin/catenin  complex  by EGTA in- 
creases EC permeability (Lampugnani et  al.,  1992).  The 
effect of EGTA presents  many similarities  with  that  of 
PMN  adhesion.  It  is  rapid  (maximal  effect  within  5-10 
min)  and leads to a  complete disappearance  of VE-cad- 
herin  and  catenins  at  EC  contacts  (Lampugnani  et  al., 
1992; Ayalon et a1.,1994; Dejana et al., 1995). 
As shown in Fig. 11, PMN adhesion to TNF-treated EC 
increased HRP permeability in a way comparable to that 
induced by 2 mM EGTA. TNF treatment alone or addi- 
tion of PMN to resting EC did not change this parameter. 
Consistent with the effect on endothelial AJ disorganiza- 
tion, PMN treatment with the anti-132 blocking mAb TS1/ 
18,  treatment with either the cocktail of protease inhibi- 
tors (100 U/ml aprotinin, 500 ixM leupeptin, and 30 I~g/ml 
eglin C), or the combination of 300 U/ml of both SOD and 
catalase was ineffective. 
Finally,  since  T-lymphocyte adhesion  to  EC  did  not 
change AJ organization, we investigated whether addition 
of T-lymphocytes could affect EC monolayer permeability. 
In these experiments, EC were treated with TNF and 
T-lymphocytes were  treated  with  PMA as  described  for 
Fig. 9. Permeability was measured as described above for 
PMN  adhesion  to  EC.  Adhesion  of T-lymphocytes in- 
duced only a 33--40% increase in permeability (range of two 
experiments)  with respect to the permeability of control 
EC treated with TNF and PMA in the absence of T-lym- 
phocytes. This value was ~10 times less than the percent- 
age increase in permeability induced by an equal number 
of adhering PMN. 
These data suggest that the dissociation of VE-cadherin 
and catenin complex induced by PMN decreases the ca- 
pacity of EC to limit the passage of soluble high molecular 
weight molecules through the junctions. 
PMN Adhesion to EC In Vivo Changes 
VE-cadherin Distribution 
We  investigated  VE-cadherin  localization  in  tissue  sec- 
tions of five cases of chronic recurrent tonsillitis by immu- 
nohystochemistry. In postcapillary high endothelial venules 
without trafficking cells, immunostaining for VE-cadherin 
was localized at endothelial cell-to-cell contacts (Fig. 12 a). 
High endothelial venules with adherent PMN showed a re- 
duction of VE-cadherin expression that was no longer de- 
tectable at the intercellular borders (Fig. 12 b). 
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cyte (LYMPHO) adhesion on 
et-catenin and plakoglobin lo- 
calization  at  EC  junctions. 
EC activated with TNF (100 
U/ml, 20 h;  c  and  d)  or  an 
equal  amount  of  buffer  (a 
and b) were double stained 
for a-catenin and plakoglo- 
bin.  Either  resting or PMA 
(10  nM)-activated  T-lym- 
phocytes (3  ×  106/ml) were 
added  to  EC  for 10 min  at 
37°C. et-Catenin  and  plako- 
globin  staining  was  concen- 
trated in the regions  of cell- 
to-cell  contact  either  in  the 
absence  (a  and  b)  or  pres- 
ence (c and d) of lymphocyte 
adhesion.  (Arrowheads) Ad- 
herent T-lymphocytes.  Com- 
parable  data  were  obtained 
when  EC  were  double 
stained  with  VE-cadherin 
and 13-catenin. Bar, 10 txm. 
Discussion 
PMN adhesion to the vascular lining accompanies the first 
stages of the acute inflammatory reaction. In response to 
chemokines and to the  expression of EC adhesive mole- 
cules, PMN first roll on the endothelial surface. This stage 
is then followed by a  more firm adhesion,  and then by a 
rapid  transmigration  of  PMN  through  EC  intercellular 
junctions (Carlos and Harlan, 1994; Springer, 1994; Imhof 
and Dunon, 1995).  Adhesion is required for PMN extrava- 
sation, but  the  mechanisms that regulate  the  opening of 
EC junctions and the passage of PMN are still obscure. 
PMN interaction with EC in vivo also controls fluid ef- 
flux through the blood vessel wall leading to tissue oedema 
(Wedmore and Williams, 1981; Yi and Ulich, 1992).  While 
the  role of PMN in  this process was clearly determined, 
the manner in which these cells increase vessel permeabil- 
ity remains obscure. 
In this study, we found that PMN adhesion to EC mono- 
layers induces endothelial AJ disassembly. Upon adhesion 
of PMN, VE-cadherin and associated catenins (et-catenin, 
~-catenin, and plakoglobin) disappeared from endothelial 
AJ. This effect was rapid, maximal within 5 min, and not 
related to EC retraction or toxicity. F-actin and PECAM-1 
staining of EC showed that, within the time frame of the 
experiments, EC monolayers remained intact and the PE- 
CAM-1  amount  and  distribution  was  essentially  unaf- 
fected. 
Immunoprecipitation and Western blot  analysis of AJ 
components showed  that,  while  the  amount  of VE-cad- 
herin and ot-catenin was only partially decreased,  ~-cate- 
nin and plakoglobin were markedly reduced. 
oL-Catenin  does not directly bind to VE-cadherin, but it 
associates to the complex via its binding to [3-catenin and 
plakoglobin  (Aberle  et  al.,  1994;  Htilsken  et  al.,  1994). 
Therefore, the total ~-catenin coimmunoprecipitated with 
VE-cadherin is the sum of the amount of ~-catenin associ- 
ated to both 13-catenin and plakoglobin. It is therefore con- 
ceivable that the total decrease in ot-catenin, observed af- 
ter PMN adhesion to EC, is lower than that of the other 
two catenins. 
The fact that VE-cadherin disappeared in immunofluo- 
rescence and was only partially decreased in immunopre- 
cipitation  might be  seen  as  a  discrepancy.  Since  only a 
small  amount  of VE-cadherin  (<30%)  was  internalized 
(see Results), it is likely that the majority of the molecule 
simply diffuses on the cell surface after PMN adhesion. In 
other conditions,  it was found that, when VE-cadherin  is 
not organized and clustered at junctions,  it is poorly de- 
tectable in immunofluorescence staining even if its amount 
on the cell surface is not reduced (see, for instance, Lam- 
pugnani et al., 1992,  1995; Dejana et al., 1995). 
We still do not know the complete mechanism that leads 
to the disorganization of VE-cadherin/catenin complex in- 
duced  by PMN;  however, their firm adhesion to the EC 
surface appears to be a prerequisite. AJ were disrupted in 
all the conditions in which PMN adhesion was significantly 
increased, including activation of EC with TNF or activa- 
tion of PMN with PMA or ~2-activating antibodies. In con- 
trast,  when PMN  adhesion  to TNF-treated EC was pre- 
vented by 132-blocking antibodies or by separating PMN by 
a Transwell filter, AJ remained intact. Furthermore, in the 
same culture well, AJ were disorganized only in areas of 
firm PMN adhesion, and they remained unchanged where 
PMN were absent. 
Through their adhesion, PMN could transfer intracellu- 
lar  signals  to  EC  in  different  ways.  One  possibility  is 
through the engagement of adhesive molecules. ICAM-1 is 
one of the major endothelial adhesive molecules for PMN 
in the conditions used in this study (i.e., long-lasting acti- 
vation of EC with TNF, activation of PMN with PMA or 
anti-132 mAb; Bevilacqua, 1993; Carlos and Harlan, 1994), 
and indeed, the blockage of the receptors for ICAM-1, by 
132 antibodies, induces inhibition of PMN adhesion and AJ 
The Journal of Cell Biology, Volume 135, 1996  506 Figure 10.  Disappearance of 
VE-cadherin  and  13-catenin 
from  cell-to-cell  contacts  is 
not prevented by PMN treat- 
ment  with  antiprotease  in- 
hibitors  or  oxygen  metabo- 
lite  scavengers.  EC  were 
double stained  for oL-catenin 
and  plakoglobin.  The  stain- 
ing of both catenins was con- 
centrated at cell-to-cell  con- 
tacts  in  TNF-activated  (100 
U/ml,  20  h)  EC  in  the  ab- 
sence of PMN (a and b). Ad- 
hesion  of  resting  PMN  (5 
min, 37°C) induced the disap- 
pearance  of  t~-catenin and 
plakoglobin  staining  at  en- 
dothelial  AJ (c and d). When 
PMN  adhesion  was  per- 
formed in the presence of a 
cocktail  of  protease  inhibi- 
tors  (100  U/ml  aprotinin, 
500 ~M leupeptin, 30 I~g/ml 
eglin C; e and 3') or of a com- 
bination of SOD and catalase 
(300 U/ml both; g and h), the 
disappearance  of  ct-catenin 
and plakoglobin was not in- 
hibited. Treatment of resting 
EC  with  a  combination  of 
elastase and cathepsin G  (1 
izg/ml  both;  i  and j)  for 5 
min at 37°C did  not change 
a-catenin  and  plakoglobin 
localization  at EC junctions. 
Comparable  observations 
were  made  by  staining  EC 
with  VE-cadherin  and 
et-catenin  antibodies.  (Ar- 
rowheads)  Adherent  PMN. 
Bar, 10 ~m. 
disruption. ICAM-1 clustering triggers tyrosine phosphor- 
ylation of cytoskeletal proteins possibly relevant in AJ as- 
sembly, such as  cortactin  and  src  (Durieu-Trautmann  et 
al., 1994). However, in preliminary experiments when we 
induced  clustering  of  ICAM-1  by  ICAM-1  antibody- 
coated beads, or by adding  ICAM-1 antibodies followed 
by secondary IgG, we did not observe any change in en- 
dothelial AJ organization  (not shown).  In addition,  lym- 
phocyte adhesion to EC, also largely mediated by ICAM-1 
(Springer, 1994), did not change AJ. Overall, this data sug- 
gest  that  during  PMN  adhesion  and/or  interaction  with 
ICAM-1, some  additional  mechanisms are  necessary for 
the observed changes in endothelial AJ to take place. 
Other  authors  (Huang  et  al.,  1993;  Pfau  et  al.,  1995) 
have reported that during the adhesion of PMN and natu- 
ral killer cells, EC cytosolic Ca  e+ level was increased, and 
addition  of  intracellular  Ca  2+  scavengers  blocks  PMN 
transmigration. A  possible model is that PMN adherence 
could  induce  a  series  of EC  intracellular  responses  that 
cause detachment of catenins from VE-cadherin. The cy- 
toplasmic-free catenins have a  short half-life (Kowalczyk 
et  al.,  1994),  and  they  are  usually  destroyed  within  few 
minutes. This would be consistent with the parallel disap- 
pearance of catenins from both VE-cadherin complex and 
total cell extracts reported here. 
Biologically active intracellular proteins are usually de- 
graded by lysosomes, the ubiquitin-proteasome system, or 
calpain-dependent  proteolysis (Ciechanover,  1994;  Saido 
et al., 1994).  A  possibility is that the increase in cytosolic 
Ca  2÷ could activate calpain, which in turn could be respon- 
sible  for  VE-cadherin/catenin  complex  dissociation  and 
catenin  lysis. This might be a  mechanism similar to that 
observed  by  other  authors  who  have  reported  that  the 
N-cadherin cytoplasmic tail could be partially digested by 
calpain (Covault et al., 1991). 
An  alternative  explanation  for  AJ  disorganization  is 
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Figure 11.  PMN adhesion increases EC permeability. EC mono- 
layers were grown to confluence on Transwell inserts, and then 
exposed for 20 h to 100 U/ml TNF (solid bars) or to control me- 
dium (grid bars). Before addition to EC, PMN were treated with 
TS1/18  mAb (1:100 final dilution, for 20 min: +anti [32) or SOD 
and catalase (300 U/ml both, for 20 min: +SOD+CAT), or with a 
cocktail of protease inhibitors (100 U/ml aprotinin, 500 p.M leu- 
peptin, 30  I~g/ml eglin C, for 30 min:  +P/). These agents were 
kept in the culture medium during EC permeability assay. Per- 
meability of EC monolayers to HRP was tested at 60 min. HRP 
enzymatic activity was measured as described (Ortiz de Montell- 
ano et al., 1988; Navarro et al., 1995). Resting EC, in the presence 
or absence of resting PMN, presented low permeation to HRP. 
Addition of EGTA (2 mM) increased permeability by threefold. 
TNF treatment, per se, did not increase EC permeability, but ad- 
dition of PMN induced a marked increase in the passage of HRP 
that was counteracted by the anti-J32 mAb but not by SOD  in 
combination with catalase or by protease inhibitors. 
that PMN locally release lytic enzymes that can in turn be 
responsible for VE-cadherin digestion and junction disas- 
sembly. This is unlikely, however, since VE-cadherin re- 
mains in large part on the cell membrane, and catenin di- 
gestion seems to be essentially an intracellular process. In 
addition, protease inhibitors were ineffective in blocking 
the  action  of  PMN  on  AJ  and  vice  versa;  addition  of 
elastase and  cathepsin  G  to the  culture medium did not 
modify endothelial junctions. Moreover, the lack of effect 
of superoxide scavengers strongly suggests that also these 
metabolites, even if potentially toxic for EC (Sacks et al., 
1978; Weiss et al., 1981), do not play a major role in disor- 
ganizing endothelial AJ in our experimental conditions. 
We cannot exclude that adhesion of PMN could create a 
microenvironment where active toxic mediators are gener- 
ated and protected by inhibitors present in the culture me- 
dium. It has been shown recently that activated PMN can 
express a surface-bound elastase and cathepsin G  that are 
particularly  resistant  to  serum  inhibitors  (Owen  et  al., 
1995).  These  membrane-bound  enzymes  or  other  active 
components  could  signal to  endothelial cells and  induce 
intracellular modifications leading to AJ disruption. How- 
ever,  for  the  expression  of  these  membrane-bound  en- 
zymes,  PMN  should  be  strongly activated (Owen  et  al., 
1995). Here we describe AJ disappearance even with rest- 
ing PMN, either adherent to TNF-treated EC or after ad- 
dition of an anti-[32-activating mAb that causes little PMN 
activation and degranulation  (Ortlepp et  al.,  1995).  Fur- 
thermore,  addition  of  activated  PMN  membrane  frag- 
ments to EC was without effect. 
An important question is what is the biological signifi- 
cance of PMN-induced AJ disorganization. We have pre- 
viously observed that agents that increase endothelial per- 
meability,  such  as  thrombin  or  EGTA,  quickly  disrupt 
Figure  12.  PMN  adhesion  to 
the vessel wall in vivo changes 
VE-cadherin  distribution  at 
endothelial cell-to-cell  contacts. 
Human  tonsil  site  of  chronic 
recurrent  tonsillitis  immuno- 
stained  for  VE-cadherin.  In 
high endothelial venules without 
trafficking leukocytes, VE-cad- 
herin is expressed at the inter- 
cellular borders (black arrows). 
In  the  area where  a  PMN  is 
sticking (white arrowhead), the 
immunostaining  of  VE-cad- 
herin is reduced, and  it is no 
longer detectable at cell-to-cell 
contacts. (a and b) Two differ- 
ent areas from the same immu- 
nostained typical section. Avi- 
din-biotin-peroxidase  complex 
counterstained with haematox- 
ylin. 
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biet et al., 1996). In addition, truncation of the cytoplasmic 
tail of VE-cadherin, to prevent its binding to catenins, in- 
creases monolayer permeability to high molecular weight 
molecules  (Navarro  et al., 1995).  It is therefore  conceiv- 
able that the disruption of VE-cadherin/catenin complex 
could  be  associated  with  an  increase  in  endothelial cell 
permeability observed in vivo during PMN infiltration in 
inflamed areas (Wedmore and Williams, 1981; Yi and UI- 
ich, 1992). We report here, by an in vitro assay, that PMN 
adhesion  to  EC  increases  permeability  in  a  way  that is 
comparable to EGTA. EGTA could be considered a suit- 
able positive control since, in a similar way to PMN adhe- 
sion, this agent causes a rapid and complete disappearance 
of AJ components without changing PECAM-1  distribu- 
tion or inducing EC retraction (Ayalon et al., 1994; Dejana 
et al., 1995). Furthermore, as for AJ disruption, proteases 
and  superoxide  inhibitors  did  not change  PMN-induced 
increase  in  permeability,  while  the  integrin  132-blocking 
mAb did so. 
Another relevant point is whether, besides permeability, 
AJ  disorganization could facilitate  PMN  transmigration. 
Even if we still do not have direct evidence for this argu- 
ment,  in  preliminary  experiments,  we  observed  that 
EGTA treatment of EC monolayers increased PMN ran- 
dom passage (Del Maschio, A., A. Zanetti, and E. Dejana, 
manuscript in preparation). This observation, albeit incon- 
clusive, is suggestive for this possibility. 
In conclusion, this work shows that PMN adhesion could 
trigger  VE-cadherin/catenin  complex  disorganization  in 
EC.  This effect  seems  to be also detectable  in vivo.  We 
suggest that AJ disruption could be important in mediat- 
ing key steps of acute inflammatory reaction, such as vas- 
cular oedema and PMN infiltration at sites of microorgan- 
ism invasion. 
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